ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2141

Interphalangeal Intra-Articular Injection With Triamcinolone Hexacetonide: Assessment Of effectiveness  In Hand Osteoarthritis

Natalia de Oliva Spolidoro1, Jamil Natour2, Rita N.V. Furtado3, Flavia S. Machado3 and Hilda A. Oliveira4, 1Rheumatology Division, Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 2Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, 3Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 4Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: joint procedures and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects II: Symptoms and Therapeutics in Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Despite being a very prevalent joint condition, there is a lack of studies on the effectiveness of the intra-articular injection (IAI) of corticosteroids in interphalangeal joints (IPs) with osteoarthritis (OA).

Methods: A randomized, controlled, double-blind trial was carried out involving 60 OA hands patients (proximal or distal IPs), allocated in two groups. The TH/LD group (n=30) received IAI in the most symptomatic IP with 0.1ml of 2% lidocaine and triamcinolone hexacetonide(TH) at a dose of 4mg(0.2ml) and 6mg(0.3ml) in the distal and proximal IPs, respectively. The LD group (n=30) received IAI with only 0.1ml of 2% lidocaine.The patients were evaluated by blinded raters at baseline (T0) and one, four, eight and twelve weeks (T1, T4, T8 and T12) after the procedure. Outcome measures:Visual Analogic Scale(VAS: 0 to 10cm) for pain in the IP at rest (VASr) and during movement (VASm), VAS for swelling (VASs), goniometry(⁰), grip strength(kgf), pinch strength(kgf) and hand function (COCHIN questionnaire and AUSCAN index). Ultrasound evaluation: Quantitative measure (in mm) of synovial hypertrophy in palmar and dorsal joint recesses of IP injected. The level of significance in the statistical analysis was set to 5% (p<0.05).

Results:

Females accounted for 96.67%of the sample (58 patients). Mean age was 60.7 ± 8.2 years. Mean disease duration was 5.0 ± 3.6 years.Twenty-nine proximal (48.3%) and 31 distal (51.7%) IPs received IAI, with no significant differences between groups. Significant intra-group improvements (p<0.05) were found in both groups, with the exception of grip and pinch strength. Reductions in the VAS for pain at rest and during movement were found in both groups one week after IAI (p=0.000). A reduction in the VASs occurred from T4 to T12 in the TH/LD group (p=0.000), whereas a reduction in VASs only occurred at T8 in the LD group(p=0.008).Both groups exhibited goniometric improvements only at T8(p=0.02). Pulp-to-pulp and tripod pinch strength exhibited improvements beginning at T4(p=0.001) and T8(p=0.000), respectively. Hand function (COCHIN and AUSCAN) exhibited significant improvement beginning at T4(p=0.047 and p=0.000, respectively), which was maintained through to the end of the study only with regard to the AUSCAN index (p=0.001).In the ultrasound evaluation, reductions in the quantitative measure of dorsal and palmar synovial hypertrophy occurred in both groups at T4(p=0.024)and T8(p=0.005), respectively. In the intergroup evaluation VASm (p=0,014) and VASs (p=0,022) showed better response in group TH/LD. There were no statistically significant differences intergroup for other variables. No substantial adverse effects were observed.

Conclusion: Proximal and distal IPs IAI with TH was effective in reducing swelling and joint movement pain in OA hands patients.


Disclosure:

N. D. O. Spolidoro,
None;

J. Natour,
None;

R. N. V. Furtado,
None;

F. S. Machado,
None;

H. A. Oliveira,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interphalangeal-intra-articular-injection-with-triamcinolone-hexacetonide-assessment-of-effectiveness-in-hand-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology